Inhibition of Tumor Progression Locus 2 Protein Kinase Decreases Lipopolysaccharide-Induced Tumor Necrosis Factor α Production Due to the Inhibition of the Tip-Associated Protein Induction in RAW264.7 Cells
Inhibition of Tumor Progression Locus 2 Protein Kinase Decreases Lipopolysaccharide-Induced Tumor Necrosis Factor α Production Due to the Inhibition of the Tip-Associated Protein Induction in RAW264.7 Cells
复制标题
DOI:
10.1248/bpb.33.1233
复制
发表时间:
2010-07-01
影响因子:
2
通讯作者:
Sugita, Takahisa
中科院分区:
文献类型:
--
作者:
Hirata, Kazuya;Miyashiro, Masahiko;Sugita, Takahisa
The activation of mitogen-activated protein kinases (MAPKs) is critically involved in inflammatory events through mediation of the production of various inflammatory cytokines. The Tp12 (tumor progression locus 2)-MEK (MAPK/ERK kinase)-ERK (extracellular signal-regulated kinase) signaling pathway plays an essential role in the production of tumor necrosis factor alpha (TNF alpha) in macrophages stimulated with lipopolysaccharide (LPS). Here, we studied the molecular mechanisms of Tp12-mediated TNFa production using a potent Tp12 kinase inhibitor, 1,7-naphtyridine-3-carbonitrile, and LPS-stimulated RAW264.7 cells. This inhibitor was effective in suppressing the in vitro Tp12 kinase activity, and caused a significant reduction in TNF alpha production via specific suppression of the phosphorylation of MEK and ERK but not that of p38 and c-Jun N-terminal kinase (JNK). A p38 inhibitor, SB203580, also inhibited the TNFa production dose-dependently. Although the TNF alpha mRNA level was not altered by either inhibitor, the Tp12 inhibitor increased the nuclear TNFa mRNA level, while decreasing that in the cytoplasm. Tip-associated protein (TAP), a key molecule in the nucleocytoplasmic transport of TNF alpha mRNA, was up-regulated by LPS, but this increase was impaired by the Tp12 inhibitor. In all cases, SB203580 was without effect in the presence of LPS. These results suggest that the LPS-induced TNF alpha production via the Tp12-MEK-ERK signaling pathway is regulated by changing the TAP level at the nucleocytoplasmic transport level. These results improve understanding of TNF alpha regulatory mechanisms and might provide a new therapeutic strategy against inflammatory diseases.